Positive high-level results from the pivotal Phase III MIRANDA trial showed potential first-in-class tozorakimab demonstrated a statistically significant and clinically meaningful reduction in the ...
The calendar has turned to October, and we are beginning to get a clearer picture of who the contenders are and who the pretenders are. Heading into the seventh week of the campaign, here are some ...
Recent findings from research we have been carrying out at the Large Hadron Collider (LHC) at Cern in Geneva suggest that we ...
Let's be real - the sustainable living world can feel a little overwhelming. There's a product for everything, a greener ...